The reference16 of 130 · GI/Bone/Other
Peptide · categoryGradeCV
GlucagonGI/Bone/Other · Endocrine / EmergencyA3GLP-2 analog (Teduglutide)GI/Bone/Other · GI / Short bowel syndromeA1Desmopressin (DDAVP)GI/Bone/Other · Endocrine / HemostasisA1CalcitoninGI/Bone/Other · Bone / CalciumA1Teriparatide (Forteo)GI/Bone/Other · BoneA1Abaloparatide (Tymlos)GI/Bone/Other · BoneA1Substance PGI/Bone/Other · Pain signaling—1α-MSH analogsresearchGI/Bone/Other · Inflammation / PigmentationD1LarazotideresearchGI/Bone/Other · GI / Bone / OtherD0OctreotideSandostatinGI/Bone/Other · Endocrine / GIA2LanreotideSomatuline DepotGI/Bone/Other · Endocrine / GIA2LinaclotideLinzessGI/Bone/Other · GIA0PlecanatideTrulanceGI/Bone/Other · GIA0Botulinum ToxinType A (Botox, onabotulinumtoxinA)GI/Bone/Other · NeuromuscularA1Vitamin B12cyanocobalamin / methylcobalaminGI/Bone/Other · Support / AdjunctA2LivagenLys-Glu-Asp-Ala tetrapeptideGI/Bone/Other · Hepatic bioregulatorD1Grade maps one-to-one from regulatory status. CV is a cardiovascular score, 0–5, on its own axis; it never moves a grade. 77 of 130 entries state that no human dose is established.